IMP-A-SDBImplantica AG
54.20SEK+1.31%Mkt Cap: P/E:

Implantica AG engages in the research and distribution of medical implants in Switzerland and Spain. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal refl…

Key Statistics

Company
Market Cap
Enterprise Value1.46B $
Revenue (TTM)209.00K $
Gross Profit-45.05K $
Net Income (TTM)-2.03M $
Revenue/Share0.0008 USD
Last Price54.20 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees46
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-14.08
PEG
EV/EBITDA-758.94
EV/Revenue7006.54
P/S
P/B188.19
EPS (TTM)
EPS (Forward)
52W Range
51.8035% of range58.60
52W High58.60 SEK
52W Low51.80 SEK
Profitability
Gross Margin-21.56%
Oper. Margin-450.18%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-24.29%
ROA-13.87%
Growth
Revenue Growth15.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-1.50M $
CapEx (TTM)
FCF Margin-435.85%
FCF Yield
Net Debt-4.33M $
Net Debt/EBITDA2.25
Balance Sheet
Debt/Equity0.27
Current Ratio16.61
Quick Ratio16.52
Book Value/Sh0.2880 SEK
Cash/Share0.1610 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float7.60M
Insiders0.00%
Institutions11.71%
Technical
SMA 5060.12 (-9.8%)
SMA 20051.60 (+5.0%)
Beta0.79
S&P 52W Chg18.16%
Avg Vol (30d)57.24K
Avg Vol (10d)44.75K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)